Rich health data from a global Real-World Data network. Technology to enabled data access and sharing. Scientific services throughout the clinical development pathway
A Healthier Future
We share a vision of a learning health system, where artificial intelligence (AI) can make health and healthcare more personalized, precise, and predictive or even preventative.
Secure access to harmonized datasets are paramount to applying AI tools, machine learning, deep learning, federation and data analytics for research and development.
Insights and impact will multiply when data becomes a shared asset. Studies can start and finish sooner. Treatments can reach patients faster.
We enable Pharma to propel drug research with an innovative suite of solutions and services, offering unmatched capabilities across the R&D spectrum
Accessing the right global health datasets
For your research question and use case
Evidence planning requires critical information gathering while understanding the stakeholder and market landscape, patient pathways, differences in treatment protocols, variance and availability of structured health data, all of which will impact choices for data sources and access methodology.
Compliance to local data privacy regulations and ethics regulations when conducting your research and/or intelligence gathering is essential – altogether making the task feel overwhelming.
Our experience, solutions, and trusted guidance help to overcome concerns associated with data privacy and challenges with limited data accessibility, interoperability and data quality
Solution Map Across the Product Lifecycle
Advance the field of life sciences with our cutting-edge offerings, providing unique expertise across the research and development continuum.
Research & Development
Target population prioritization and characterization
Identifying subgroups of interest
Optimizing clinical trial design, inclusion/exclusion criteria
Natural history of disease
Regulatory Approval
Natural history of disease
Treatment pathways
Unmet needs
Identify suitable comparators
External control arm
HEOR Market Access
Burden of disease
Cost of illness
Health care resource utilization (HCRU)
External control arm (addressing varying standards of care)
Outcomes studies
Comparative effectiveness
Post Approval Follow Up
Outcomes studies
Comparative effectiveness
Uptake tracking